“…ASTs use phenolic sulfate esters (e.g., p ‐nitrophenyl sulfate ( p NPS), 4‐methylumbelliferyl sulfate (4‐MUS) and 1‐naphthyl sulfate) as sulfuryl donors (Kobashi, Kim, & Morikawa, ; Malojcić & Glockshuber, ) that are more cost‐efficient than PAPS. Prokaryotic sulfotransferase have usually a broad substrate scope (Kim, Yoon, Koizumi, & Kobashi, ; van der Horst et al, ) and bacterial expression systems can be used for enzyme production (Kim, Hyun, Lee, Kobashi, & Kim, ) and reengineering (Koryakina, Neville, Nonaka, Van Lanen, & Williams, ). For instance, it has been reported that ASTs are able to sulfurylate phenolic antibiotics (Kim et al, ), steroids (van der Horst, van Lieshout, Bury, Hartog, & Wever, ), flavonoids (Roubalova et al, ; van der Horst et al, ), and, as recently reported, large molecules like lignin (Prinsen, Narani, Hartog, Wever, & Rothenberg, ).…”